Safety, Tolerability, and Efficacy of Etrasimod (APD334) in Participants With Primary Biliary Cholangitis
Clinical trial NCT03155932 · TERMINATED
Trial details
- NCT number
- NCT03155932
- Sponsor
- Arena Pharmaceuticals
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-12-29
- Primary completion
- 2019-01-31
- Enrollment
- 2
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.